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Calcium homeostasisRTN1A is a reticulon protein with predominant localization in the endoplasmic reticulum (ER). It was previously
shown that RTN1A is expressed in neurons of themammalian central nervous systembut functional information
remains sparse. To elucidate the neuronal function of RTN1A, we chose to focus our investigation on identifying
possible novel binding partners speciﬁcally interactingwith the unique N-terminus of RTN1A. Using a nonbiased
approach involving GST pull-downs and MS analysis, we identiﬁed the intracellular calcium release channel
ryanodine receptor 2 (RyR2) as a direct binding partner of RTN1A. The RyR2 binding sitewas localized to a highly
conserved 150-amino acid residue region. RTN1A displays high preference for RyR2 binding in vitro and in vivo
and both proteins colocalize in hippocampal neurons and Purkinje cells. Moreover, we demonstrate the precise
subcellular localization of RTN1A in Purkinje cells and show that RTN1A inhibits RyR channels in [3H]ryanodine
binding studies on brain synaptosomes. In a functional assay, RTN1A signiﬁcantly reduced RyR2-mediated Ca2+
oscillations. Thus, RTN1A and RyR2might act as functional partners in the regulation of cytosolic Ca2+ dynamics
the in neurons.
© 2013 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Reticulons (RTNs) are a highly conserved eukaryotic protein family
residing in the endomembrane system. In mammals 4 reticulon genes
are known (RTN1–RTN4), which encode various protein isoforms [1,2].
Reticulons share little sequence homology except for the reticulon ho-
mology domain (RHD), a C-terminally located domain of ~200 amino
acids composed of two short hairpin domains separated by a highly con-
served loop-region. While their physiological relevance is still poorly
understood, recent ﬁndings suggest that reticulons partition into tubules
of the ER via their RHD and act as membrane curvature proteins respon-
sible for shaping ER-tubules and ER-sheet edges. Moreover, by inter-
acting with other hairpin loop-containing proteins, such as REEP1,
atlastin-1 and M1 spastin, RTNs appear to participate in a network of
ER morphogens [3].c reticulum; RyR, ryanodine re-
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-NC-ND license.In the mammalian nervous system the role of RTNs remains unclear,
though a variety of functions have been postulated for speciﬁc RTNs,
including vesicular andmembrane trafﬁcking [4], neuroendocrine secre-
tion [5], hereditary spastic paraplegia [6], inhibition of enzymatic activity
[7], apoptosis [8,9], and regulation of axonal growth and plasticity [10].
RTN1A, the longest isoform of the rtn1 gene, was the ﬁrst RTN protein
described to be widely expressed in the developing and mature brain
[11,12]. As opposed to the well studied Nogo/RTN4 proteins, RTN1A in
the adult brain is located exclusively in the neurons but not in the glial
cells [11]. RTN1C was shown to interact with Spastin [13], Sec61 [14]
and AP-2 [15] suggesting that it might be involved in regulating intracel-
lular vesicle transport, although a ﬁrm conclusive answer is missing.
While these interactions are mediated via the C-terminal RHD, common
to all RTNs, little is known about the variable N-terminal regions, speciﬁc
for each RTN isoform. Assuming that theN-terminal domains are special-
ized for distinct functions by associating with different target proteins,
we have set out to search for binding proteins that speciﬁcally bind to
the N-terminal domain of neuronal RTN1A. Using a GST pull-down and
co-immunoprecipitation strategy, we demonstrate for the ﬁrst time
that in rodent brain RTN1A forms a stable associationwith the ryanodine
receptor RyR2, but not the closely related family member RyR1 and that
this interaction was found to modify RyR2 channel function, as judged
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analysis. Our observations suggest that RyR2 channels may form stable
interactions with RTN1A, leading to a reduction of RyR2-mediated
Ca2+ oscillations.
RyR2 is a member of the intracellular ryanodine receptor Ca2+-
release channels (RyRs) localized in the ER. Three RyR isoforms have
been puriﬁed in mammals (RyR1, RyR2 and RyR3) that coordinate
many calcium signaling events such as muscle contraction and neuro-
transmission. RyR1 is predominant in the skeletal muscle and in the cer-
ebellar Purkinje neurons. RyR2 ismainly expressed in the cardiacmuscles
and is the predominant subtype in the brain, while the brain speciﬁc
RyR3 is weakly expressed throughout the brain [16]. RyRs contribute
to the regulation of the cytosolic calcium dynamics, by release of calcium
from intracellular Ca2+ stores as a consequence of Ca2+ inﬂux through
voltage- or ligand-gated Ca2+ channels, the so-called Ca2+-induced
Ca2+ release (CICR) [17]. CICR from the intracellular calcium stores that
ampliﬁes further the Ca2+ signal is thought to be involved in more
profound and lasting changes in neurons, regulating neurotransmitter
release, synaptic plasticity, gene expression, and signal transduction to
the nucleus [18]. Recent evidence supports a role of RyR2-mediated con-
trol of calcium homeostasis in stress-induced defects in cognitive func-
tion and postsynaptic plasticity in hippocampal neurons [19]. Moreover,
leaky neuronal RyR2 channels are also implicated in neurodegeneration,
including Alzheimer's disease and aging.
2. Materials and methods
2.1. Plasmid constructs
pcDNA3.1-RyR2 containing full length mouse cardiac RyR2 cDNA,
GenBankTM accession no. NP_076357.2 was kindly provided by
Wayne Chen (University of Calgary, Calgary; [20]), and a pCI-neo vector
(Promega)with a full length rabbit skeletal RyR1 insert (GenBank acces-
sion no. X15209) was kindly provided by P. D. Allen (Brigham and
Women's Hospital, Boston; [21]). GST-RTN1523 (aa 1–523; 5′-CTGGG
ATCCATGGCCGCA CCGCCGGATCTGCAAG-3′ forward and 5′-CAGCCCG
GGTCAATGATGATGATGATGAT GACCACGCTGAGTATCGGGTCAGGTTCC
ACAG-3′ reverse and GST-HHD (aa 376–523; 5′-AATGGATCCCCAGTG
GGCCAGGCGGCCGAC-3′ forward) and 5′-CAGCCCGGGTC AATGATGAT
GATGATGATGACCACCGCTGAGTATCGGGTCAGGTTCCACAG-3′ reverse)
were generated by PCR ampliﬁcation using rat full length RTN1A as a
template [2], and cloned into pGEX-6P (Amersham Pharmacia).
GST-LNT1 (aa 1–375, 5′-CTGGGATCCATGG CCGCACCGCCGGATCTGCA
AG-3′ forward and 5′-TCAATGATGATGATGATGATGCACTGGCCTTGGA
CTCTCGGTTG-3′ reverse) was generated by PCR ampliﬁcation using
GST-RTN1523 as a template and cloned into pGEX-6P. GST-NiR was
described previously [22]. mCherry-RTN1523 (5′-ACGAAGCTTCGCC
ACCATGGTGATGGCCGCACCGCCGGATCTG CAAG-3′ forward and 5′-
TGCGGATCCGCGCTGAGTATCGGGTCAGGTTCCACAG-3′ reverse) was
generated via PCR ampliﬁcation using rat RTN1A-eGFP as template
and cloned into mCherryN (Clontech). Restriction sites used for sub-
cloning are underlined. All constructswere veriﬁed by sequencing anal-
ysis (MWG, Ebersberg, Germany).
2.2. Expression and puriﬁcation of recombinant GST fusion proteins
Recombinant protein expression of transformed E. coli (BL21(DE3))
cells was induced with 1 mM IPTG (isopropyl-β-d-thiogalactopyrano-
side) for 4 h at 20 °C. Cells were then harvested by centrifugation and
1 g of bacterial pellet was resuspended in 4 mL of lysis buffer (50 mM
sodium phosphate buffer, pH 7.4, 150 mM NaCl, 0.1% Triton X-100,
0.05% Tween-20) supplemented with Lysozyme (1 mg/mL), Protease
Inhibitor Cocktail (Roche) and DNAse (0.1 mg/mL). The lysate was
sonicated 5 times for 15 s each (on ice) and was then cleared by centri-
fugation at 15,000 ×g for 15 min at 4 °C. For dual puriﬁcation, the
precleared supernatant was ﬁrst run over a GSTrap Afﬁnity Column(GE Healthcare) attached to a chromatography apparatus (ÄKTA prime,
GE Healthcare). Bound proteins were eluted with 50 mM reduced
glutathione in TBS, pH 8.0 containing 0.1 mM β-mercaptoethanol.
GST-puriﬁed eluate was collected, and subjected on a HisTrap Afﬁnity
Column (GE Healthcare). Bound protein was eluted with wash buffer
(50 mM sodium phosphate buffer at pH 7.4, 0.1% Triton X-100, 0.05%
Tween-20, 150 mM NaCl) containing imidazole at a ﬁnal concentration
of 500 mM. Samples of the eluated tagged puriﬁed recombinant proteins
were analyzed by SDS-PAGE and Silver Staining [23,24] and immobilized
to Glutathione Sepharose Beads (GE Healthcare) for 2 h at 4 °C.
2.3. GST pull-down assays
For in vitro GST pull-down assays, whole adult mouse brains (BL6,
10 weeks) were homogenized by 50 strokes of a dounce homogenizer
in ice-cold lysis buffer (50 mM HEPES pH 7.4, 25 mM NaCl, 10 mM
EDTA, 1% TritonX-100) and complete protease and phosphatase inhibitor
cocktail (Roche; 1:10; w/v). The homogenate was centrifuged for 30 min
at 20,000 ×g, 4 °C and supernatant was passed through a 0.45 μm ﬁlter
(BDBiosciences). 40 mgof total brain extract (10 mg/mL)was precleared
by incubation for 2 h at 4 °Cwith 0.20 mLof glutathione agarose followed
by centrifugation (500 ×g for 2 min) and assayed for protein content.
2.5 mg of the recovered brain extract (2.5 mg/mL) was incubated over-
night at 4 °C with indicated concentrations of recombinant GST-fusion
proteins immobilized to Glutathione Sepharose Beads (GE Healthcare).
GST or Glutathione agarose (0.2 mL) served as controls. Agarose beads
were washed ﬁve times in lysis buffer at 4 °C and resuspended in
Laemmli sample buffer. Samples were separated by 12.5% SDS-PAGE,
and analyzed by silver staining or immunoblotting using standard
procedures.
2.4. MS analysis
For MS analysis, silver stained protein bands were cut out and
subjected to in-gel digestion as published previously [25]. Protein digests
were analyzed using an UltiMate 3000 nano-HPLC system (Dionex,
Germering, Germany) coupled to an LTQ Orbitrap XLmass spectrometer
(ThermoScientiﬁc, Bremen, Germany) equipped with a nanospray ioni-
zation source. A homemade fritless fused silica microcapillary column
(75 μm i.d. × 280 μm o.d.) packed with 10 cm of 3 μm reverse-phase
C18 material (Reprosil) was used. The gradient (solvent A: 0.1% formic
acid; solvent B: 0.1% formic acid in 85% acetonitrile) started at 4% B.
The concentrationof solvent Bwas increased linearly from4% to50%dur-
ing 50 min and from50% to 100%during 5 min. Aﬂowrate of 250 nL/min
was applied. Protein identiﬁcation was performed using the Mascot
search engine and the NCBInr database (mus) accepting variablemodiﬁ-
cations, carbamidomethyl (C), oxidation (M). Speciﬁc cleavage sites for
trypsin (KR) were selected with twomissed cleavage sites allowed. Pep-
tide tolerancewas±10 ppm andMS/MS tolerancewas±1 Da. Peptides
with a Mascot score below 30 were skipped. Only best matches were
considered.
2.5. Co-immunoprecipitation and immunoblotting
Total brain extract was prepared from adult Sprague–Dawley cere-
bella in a manner similar to the GST pull-down experiments. 1 mg of
cleared lysate (4 mg/mL) was then incubated for 1 h at 4 °C with 5 μg
of either mouse anti-RyR2 (Clone c3-33, Pierce), mouse anti-RTN1A
(MON162; MuBio, Netherlands), mouse anti-RTN4A (clone 11C7; 22),
rabbit anti-RTN1A [2], rabbit anti-RTN4 [22] or rabbit IgG (Sigma).
25 μL of Protein G Dynabeads (Invitrogen) were then added for 1 h
and rotated at 4 °C. Beads were washed ﬁve times in lysis buffer at
4 °C and were removed from the supernatant using Dynal Magnetic
Particle concentrators (Invitrogen). Beads were boiled in Laemmli sam-
ple buffer and samples were loaded on 6% SDS-PAGE gels and blotted
onto PVDF membranes (GE Healthcare). After staining with Ponceau S
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Skim-Milk (Merck) in TBS-Tween 20 (TBS-T; 10 mM Tris-base,
150 mM NaCl, and 0.2% Tween 20, pH8.0) for 2 h at RT. Wherever fea-
sible, the PVDF membranes were probed with antibodies different
from those used for immunoprecipitation to maximize the speciﬁcity
of the immunoreactive product obtained. For RTN1A in particular, we
used either of two antibodies highly speciﬁc for RTN1A: a rabbit anti-
body speciﬁc for the cytoplasmic domain of RTN1A (1:100,000; [2])
and a monoclonal one raised against amino acids 338–422 of RTN1A
(MON162; 1:1000; MuBio, Netherlands). RyR2 was identiﬁed with a
mouse antibody recognizing all RyR isoforms (1:1000; Pierce), RyR1
with rabbit anti-RyR1 (1:1000; Alomone Labs, Israel), IP3R1with rabbit
anti-IP3R1 (1:4000; Alomone Labs, Israel) and RTN4Awith either rabbit
ormouse anti-RTN4A [22]. Primary antibody incubationwas performed
at RT for 2 h followed by several washing steps in TBST-T. Antibody
binding to proteins was detected using secondary antibody conjugated
to horseradhish peroxidase (1:20,000; Thermo Scientiﬁc) and visual-
ized by enzyme-linked chemiluminescence using ECL Detection Kit
(Amersham), and a Typhoon Scanner Device (Amersham Biosciences).
2.6. HEK293 cell culture and transfection
HEK293 cells were maintained in Dulbecco's modiﬁed Eagle's
Medium-High Glucose as previously described and transfected with
2–10 μg mouse RyR2 or rabbit RyR1 cDNAs with or without 0.2–1 μg
rat RTN1A-myc, RTN4A-myc, RTN1523-mCherry or mCherry cDNAs
using Ca2+ phosphate precipitation [26]. Cells were either lysed 40 h
post-transfection and processed for immunoprecipitation as described
above or ﬁxed in 4% paraformaldehyde for 15 min, permeabilized in
0.1% Triton-X100 in PBS for 20 min and immunostained using mouse
monoclonal antibodies against RyR2 (1:1000; Clone c3-33, Pierce), or
RyR1 (1:500; Alomone Labs, Israel), followed by subsequent detection
using secondary antibodies conjugated toAlexa488 (1:1000; Invitrogen).
Single cells transfectedwith untagged RyR1 or RyR2were double stained
with rabbit anti-calreticulin (1:500; Abcam) and mouse pan-RyR anti-
body (1:1000; Pierce). Images were captured using a Leica SP5 micro-
scope and a Leica PL APO 63×/1.4 oil-immersion lens. Quantiﬁcation of
colocalization depicted is an average of 10 independent cells per group.
Colocalization and quantiﬁcationwere performed using Pearson's coefﬁ-
cient of colocalization of red and greenﬂuorescent signals captured of the
same microscopy ﬁeld, using the LAS AF software (Leica, Mannheim,
Germany).
2.7. Ca2+-imaging
Transfection of HEK cells [27] was performed using TransFectin
(Biorad, Germany) with the corresponding plasmids, i.e. 2 μg RyR2,
0.2 μg mcherry or 0.3 μg of either mcherry-RTN1A or EGFP-RTN4A.
Measurements were carried out 24 to 48 h following transfection.
Employing Fura-2 microscopy, transfected HEK293 cells grown on
coverslips for 1–2 days were loaded with Fura-2/AM (1 μM) for
30 min at room temperature in an extracellular, nominally Ca2+
free solution (0 mM Ca2+: 140 NaCl, 5 KCl, 1 MgCl2, 10 glucose, 10
Hepes, pH 7.4 (NaOH)) and mounted at an inverted Axiovert 100 TV
microscope (Zeiss, Germany). Excitation of Fura-2 was performed at
340 nm and 380 nm, and Ca2+ measurements are shown as 340/380
ratios of transfected HEK293 cells which were corrected for EGFP
crossexcitation in the case of EGFP-RTN4A. To evoke Ca2+ oscillations
according to [28] the nominally Ca2+ free solution was exchanged by
a 1 mM Ca2+ extracellular solution (140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2,
10 glucose, 10 Hepes, pH 7.4 (NaOH)). The amount of Ca2+ released
during oscillations over a 450 s time-period was estimated by the
cumulative area of the oscillations peaks. Transfected HEK293 cells
were identiﬁed by their mcherry or EGFP ﬂuorescence and a response
to 10 mM caffeine in nominally Ca2+-free solution which was taken
as an indicator for RyR2 expression.2.8. Animals, tissue preparation and immunohistochemistry for light and
electron microscopy
Adult male Sprague Dawley rats (300–400 g; Dept. Laboratory
Animals and Genetics, Medical University Vienna, Vienna, Austria)
were used for light and electron microscopy experiments. All exper-
imental protocols were approved by the Austrian Animal Experi-
mentation Ethics Board in compliance with both the European
Convention for the Protection of Vertebrate Animals used for Experimen-
tal and Other Scientiﬁc Purposes (ETS no. 123) and the European Com-
munities Council Directive of 24 November 1986 (86/609/EEC). Every
effort was made to minimize the number and suffering of the animals
used. Animals were deeply anesthetized by intraperitoneal injection of
thiopental (100 mg/kg, i.p.) and perfused transcardially with phosphate
buffered saline (PBS; 25 mM, 0.9% NaCl, pH 7.4) followed for 15 min by
ice-cold ﬁxative made of 4% w/v paraformaldehyde, for light microscopy
experiments, or with the addition of 15% v/v of a saturated solution of
picric acid and 0.05% glutaraldehyde immediately before the perfusion
for pre-embedding electron microscopy. Brains were then immediately
removed from the skull, washed in 0.1 M phosphate buffer (PB) and
sliced coronally in 40 or 70 μm thick sections on a vibratome (Leica
Microsystems VT1000S, Vienna, Austria). Sections were stored in
0.1 M PB containing 0.05% sodium azide at 6 °C.
Adjacent free ﬂoating 40 μm sections were permeabilized in 0.4%
Triton X-100 (TBS-T) for 30 min, blocked with 10% normal goat serum
in TBS-T, and incubated for 65 h at 4 °C with polyclonal rabbit antibodies
directed against RTN1A (1:2000; 2) or RyR 2 (1:2000; [16]). After three
consecutive washes in TBS-T, the sections were incubated with HRP-
coupled secondary antibody (P0448 goat anti-rabbit 1:500; DAKO,
Glostrup, Denmark) in 10% blocking serum/TBS-T) for 2.5 h. Immuno-
reactions were visualized using 3,3′-diaminobenzidine tetrahydro-
chloride dihydrate (DAB, Sigma-Aldrich,Vienna, Austria). Sections were
mounted on glass slides in 60% ethanol and allowed to dry overnight.
After dehydration in ethanol and clearing in butyl acetate, they were
coverslipped using Eukitt mountingmedium. Controls included omission
of the primary serumor its substitution by nonimmune rabbit serum, and
no speciﬁc staining was visible on such preparations. In some experi-
ments, RTN1A antibody solution has been pre-incubated with excess of
recombinant RTN1A or RACK protein (10 μg/mL) at 4 °C overnight. Stain-
ing was absent in sections pretreated with such a solution (Suppl. Fig. 1).
Analysis was performed under a Zeiss AxioPhot microscope equipped
with Plan-Neoﬂuar and Plan-Apo objective lenses (Zeiss, Vienna, Austria).
Images were acquired with an AxioCam HR (Zeiss) controlled by the
Openlab software (version 5.5.0; Improvision, Coventry, UK). For immu-
nohistochemistry, sections for pre-embedding electron microscopy
were incubated with the mouse monoclonal RTN1A MON162 antibody
(diluted 1:250) and the antigen-antibody complex was visualized either
by HRP or by nanogold-silver-enhanced reaction. Sections processed for
theHRP reactionwere incubatedwith biotinylated anti-mouse secondary
antibodies (diluted 1:100; Vector Laboratories) and then in ABC complex
(diluted 1:100; Vector Laboratories) made up in TB overnight at 6 °C.
Visualization was carried out with DAB (0.5 mg/mL) using 0.003% H2O2
for 3–6 min. For the nanogold-silver-enhanced reaction, sectionswere in-
cubated with Fab fragment secondary antibodies coupled to nanogold
(1.4 nm, Nanoprobes Inc., Stony Brook, NY) and then extensively washed
in milliQ water before silver enhancement of the gold particles with the
HQ kit (Nanoprobes Inc.) for ~8–10 min. After both reactions, sections
were subsequently washed with 0.1 M PB and treated with 2% OsO4 in
0.1 M PB for 40 min at RT and contrasted with 1% uranyl-acetate in 50%
ethanol for 30 min at RT. Sections were dehydrated and transferred into
epoxy resin (Durcupan ACM, Sigma-Aldrich, Gillingham, UK) overnight
at RT. The following day, the sections were transferred onto greased
slides, coverslipped, and incubated for 3 days at 60 °C. Blocks of the
cerebellar cortex were cut under a stereomicroscope and re-embedded
in epoxy resin. Ultrathin sections (70 nm) were cut using a diamond
knife (Diatome, Biel, Switzerland) on an ultramicrotome (Ultracut,
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analyzed at 80 kV in a Philips CM120 electron microscope (Eindhoven,
the Netherlands).
2.9. [3H]Ryanodine Binding Assay
Preparation of puriﬁed rat forebrain synaptosomalmembrane vesicles
was described previously [29]. Equilibrium [3H]ryanodine binding was
essentially performed as described [30,31]. Brieﬂy, 200 μg vesicles
(12.5 μg/mL) were incubated at 0.5 M or 1 M KCl, 25 mM Pipes, pH 7.4
and varying free calcium concentrations, with 10 nM [3H]ryanodine
(American Radiolabeled Chemicals Inc., St. Louis, MO) for 2 h at 37 °C in
the presence or absence of 0.1 μM GST-RTN523 or 0.1 μM GST as control.
Nonspeciﬁc binding was determined by measuring [3H]ryanodine bind-
ing in the presence of 10 μM unlabeled ryanodine (Ascent Laboratories,
UK). Bound [3H]ryanodine was separated from free ligand by vacuum
ﬁltering through glass ﬁber ﬁlters (Whatman GF/C). Filters were washed
3 times with 5 mL each of ice-cold 10% binding buffer (0.1 M KCl,
2.5 mM Pipes, pH 7.4). Radioactivity was quantiﬁed by liquid scintilla-
tion counting. Speciﬁc binding was calculated as the difference between
total and nonspeciﬁc binding measured in parallel assays. All binding
assays were done in triplicates. Results shown are means +/− S.E.M.
for n = 3–4 independent experiments. Statistical signiﬁcance was eval-
uated using Student's t-test. [Free Ca2+ concentrations were calculated
using MaxChelator software. (http://www.stanford.edu/~cpatton/maxc.
html)].
3. Results
3.1. Identiﬁcation of RyR2 as a binding partner of RTN1A
To better understand the function of neuronal RTN1A, we searched
for protein-binding partners using pull-down experiments from mouse
brain extracts with a GST-His-tagged fusion protein comprising aa 1–
523 of rat RTN1A (GST-RTN1523) (Fig. 1A). Speciﬁcally bound proteins
were resolved by SDS-PAGE and visualized by Silver staining. One prom-
inent band at high molecular weigth was consistently pulled down with
varying amounts of the GST-RTN1523 (Fig. 1A, arrow). This band was not
seen in control lanes using GST, glutathione beads or GST-NiR, a recom-
binant fusion protein comprising aa 1–172 of rat reticulon protein
NogoA/RTN-4A (Fig. 1A). We excised this band and subjected it to MS
analysis, which identiﬁed 25 different peptides that belong to the cardiac
RyR2, an ER-associated calcium-release channel, expressed in heart and
brain (Suppl. Fig. 2; [32]). The association of GST-RTN1523 and RyR2
was conﬁrmed by Western blotting with an antibody speciﬁc for RyR2
(Fig. 1B). Two immunoreactive bands larger than 500 kDa, consistent
with the size of RyR2, were detected. The higher molecular mass band
correspondsmost likely to intact RyR2, while the lower band presumably
represents a proteolytic degradation fragment of RyR2. The intensity of
the RyR2 bands increased proportionally with increasing amounts of
GST-RTN1523. Taken together, these results demonstrate that in vitro
the RTN1A/RyR2 interaction was robust and concentration-dependent
as GST-RTN1523 was increased.
3.2. RTN1A associates with RyR2 in vitro and in vivo
To verify that RTN1A and RyR2 interact in a cellular system, we
performed both in vitro and in vivo co-immunoprecipitation experi-
ments. Full length myc-tagged RTN1A and untagged RyR2 were
cotransfected into HEK293 cells, which lack endogenous expression of
RTN1A or RyR2. As expected, RyR2 was readily co-immunoprecipitated
with RTN1A (Fig. 2A), but not in the control experiments, when RyR2
was co-expressed with RTN4A-myc or if non-immune rabbit IgG was
used as the precipitating antibody (Fig. 2A). Expression levels of
RTN1A, RTN4A, and RyR2were comparable between transfections as in-
dicated by immunoblotting a fraction of the immunoprecipitation inputs(Fig. 2A). This shows that full length RTN1A can associate with RyR2
after heterologous expression in HEK293 cells.
Next we addressed if RyR2 and RTN1A interact under endogenous
conditions in brain tissue. Because both RTN1A and RyR2 are expressed
in the cerebellum [33,11] we employed reverse co-immunoprecipitation
experiments using anti-RTN1A antibodies to precipitate RTN1A from rat
cerebellar homogenate. Again, RyR2 was found to co-precipitate robustly
with two different RTN1A antibodies. In contrast, RyR2 was not im-
munoprecipitated with non-immune IgG or two different anti-RTN4A
antibodies, indicating the speciﬁcity of the co-immunoprecipitation
(Fig. 2B,C). When RyR2 was immunoprecipitated using RyR2 speciﬁc
antibodies, only RTN1A but not RTN4A was robustly precipitated with
RyR2, again supporting a speciﬁc association of RTN1A and RyR2
(Fig. 2C). Moreover, RTN1A's in vivo interaction with RyR2 was isoform
speciﬁc as it interactswith RyR2, but notwith RyR1 (Fig. 2D) or InsP3R1,
another ER-associated calcium release channel abundantly expressed in
the cerebellum (Supp. Fig. 3; [33,34]). Our immunoblots also indicate
that RTN1A associates with RTN4A, as rabbit anti-RTN1A antibodies
co-precipitated RTN4A (Fig. 2B, lane 2). Similarly, RTN1A was weakly
detected in immunoprecipitates with monoclonal anti-RTN4A antibod-
ies (Fig. 2C, lane 4). This is in line with previous reports, showing that
RTNs can form hetero-oligomers via their RHD domains [35,36].
Together, the results from these co-immunoprecipitation experi-
ments suggest that RTN1A associates speciﬁcally with the RyR2 channel
in the brain and possibly forms complexes composed of additional
reticulon isoforms.
3.3. RyR2-dependent redistribution of RTN1523 in HEK293 cells
As an independent veriﬁcation of the data, we expressed mCherry-
RTN1523, alone or in the presence of the RyR2 receptor in HEK293
cells, and examined the subcellular distribution of the RTN1523 con-
struct. Expression of mCherry-RTN1523 lacking the RHD displayed a dif-
fuse distribution in the cytoplasm (Fig. 3A, a), conﬁrming that the RHD
of reticulons plays a role in targeting and stabilization of the proteins
in the ER membrane [37,38]. In comparison, immunocytochemical
stainings of cells single-transfected with untagged RyR2 or RyR1 re-
vealed awell deﬁned and typical staining pattern of ER targeted proteins
with a highly organized web-like distribution throughout the cell
(Fig. 3A,b–c).
Double immunoﬂuorescence staining conﬁrmed that both RyR
isoform proteins are localized to the ER as evidenced by the strong
colocalization of their staining with calreticulin, an endogenous ER
marker (Fig. 3B). Interestingly, co-expression of mCherry-RTN1523
with RyR2 resulted in a partial redistribution of RTN1523 from cytosolic
to ER location, overlapping with RyR2 in the perinuclear region as well
as tubular network (Fig. 3A, d–f). Notably, the redistribution of RTN1523
was speciﬁcally dependent on its interaction with RyR2, as RTN1523
maintained a diffuse localization in the cytosol when it was co-
expressed with RyR1 (Fig. 3A, g–i), that was unable to bind RTN1A
(Fig. 2D). As a result, the rate of colocalization as quantiﬁed by using
the Pearson's correlation coefﬁcient was much higher between
RTN1A523 and RyR2 (Pearson's coefﬁcient = 0.76 ± 0.10) than between
RTN1A523 and RyR1 (Pearson´s coefﬁcient = 0.28 ± 0.09; p = 0.003)
(Fig. 3C). Thus, the colocalization between RTN1523 and RyR2 supports a
highly speciﬁc direct interaction of both proteins.
3.4. RyR2 binds to a conserved domain in the N-terminal region of RTN1A
To deﬁne more speciﬁcally the RyR2 binding region within RTN1A,
we generated two non-overlapping sub-fragments of RTN1523 (long
N-terminal fragment, LNT, aa 1–375; high homology domain, HHD, aa
376–523; Fig. 4A) and performed GST pull-down assays on mouse
brain lysates. As shown in Fig. 4B, RyR2 speciﬁcally interacted with
GST-RTN1523 and GST-HHD, but not with GST-LNT or the negative con-
trols (Fig. 4B, upper panel). These data indicate that the HHD domain, aa
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Fig. 1. Identiﬁcation of RyR2 as a binding partner of RTN1A. (A) Schematic representation of full length RTN1A and the GST-RTN1523 construct (right). RHD: reticulon homology
domain; TM1 and TM2: transmembrane domain 1 and 2. GST pull-downs were performed with GST-RTN1523 using detergent-solubilized mouse brain proteins. GST or empty glu-
tathione beads served as negative controls, whereas GST-NiR was tested to control for GST-RTN1523 binding speciﬁcity. Arrow denotes protein band that was consistently pulled
down with GST-RTN1523 and from which RyR2 was identiﬁed by mass spectrometry. Note that this band is absent in the different control samples. Asterisks indicate the GST fusion
proteins and their relative amounts used in the GST pull-down. The silver stained gel shown is representative of three independent experiments. (B) Upper panel, Western Blot of
samples from (A) probed with RyR2 antibody. Note the double-band that is identiﬁed as RyR2. The higher molecular mass band corresponds to intact RyR2, while the lower band
presumably represents a proteolytic degradation fragment of RyR2. The intensity of the RyR2 bands increase with increasing amounts of GST-RTN1523. Lower panel, shows Ponceau
S staining of the pull-downs to assess the relative amounts of each GST fusion protein. Input lane shows one-twentieth of the amount used for pull-down. WB, Western blot. The
Western blot shown is representative of three independent experiments.
1425L. Kaya et al. / Biochimica et Biophysica Acta 1833 (2013) 1421–1433376–523 of RTN1A, contains the binding site(s) for RyR2 in vitro. Inter-
estingly, this regionwas found to display signiﬁcant sequence homology
from human to Xenopus, (thus we termed this region high homology
domain, HHD), suggesting that this domain was highly conserved over
evolution.
3.5. RTN1A displays an overlapping expression pattern with RyR2
in brain
RTN1A and RyR2 have been both reported to be expressed in brain
[11,12,39–41]. Because our GST fusion protein afﬁnity pull-down and
co-immunoprecipitation experiments from total brain or cerebellar
extracts provide biochemical evidence for the association of RTN1A
and RyR2 in a complex, we predicted that their expression patterns
would overlap. To address this hypothesis, we examined the distribution
of RyR2 and RTN1A in different regions and cell types of the brain usingimmunohistochemical analysis on adult rat brain sections. Indeed,
RTN1A and RyR2 were found to be codistributed in many brain regions,
although their staining patternwas not identical. The highest immunore-
activity of both RTN1A and RyR2 was in the hippocampus and cerebellar
Purkinje neurons (Fig. 5). In line with a previous study, RyR2 displayed
intense immunoreactivity in the molecular layer of the dentate gyrus as
well as in mossy ﬁbers and stratum lucidum, a region of high synaptic
plasticitywheremossyﬁbers synapsewithCA3pyramidal cell apical den-
drites (Fig. 5B; [40]). A similar staining pattern was found for RTN1A
(Fig. 5A), revealing strong expression in mossy ﬁbers and stratum
lucidum. In the adult rat cerebellum, two independent anti-RTN1A anti-
bodies revealed a strong immunoreactivity in Purkinje cell somata,
axons and dendrites whereas cerebellar interneurons, Bergman glia and
granule cells remained unlabeled (Fig. 5C, D). Consistent with previous
reports, immunoﬂuorescent RyR2 speciﬁc staining was predominantly
found in granule cells, and more moderatly in Purkinje cell somata and
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Fig. 2. RTN1A associates preferentially with RyR2 channel in vivo. (A) Left panels, detergent-solubilized protein from HEK293 cells transiently transfected with untagged RyR2 plus
RTN1A-myc was immunoprecipitated (IP) with rabbit polyclonal anti-RTN1A antibodies or control rabbit IgG. Immunoprecipitated proteins were detected on immunoblots with
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ies. Input lane shows one-ﬁfth of the amount used for immunoprecipitation. WB, Western blot.
1426 L. Kaya et al. / Biochimica et Biophysica Acta 1833 (2013) 1421–1433dendrites (Fig. 5E; [40]). Unfortunately, our attempts to reveal double
immunoﬂuorescent staining for RTN1A and RyR2 showed somewhat
variable results due to inconsistencywith themonoclonal RyR2 antibody.3.6. Subcellular localization of RTN1A by immuno EM
Next, to resolve the precise subcellular distribution of RTN1A in
Purkinje cells, we carried out pre-embedding immunoelectron mi-
croscopy visualizing the antigen-antibody complex either by means
of the HRP-DAB reaction, because of the higher sensitivity, or by
silver-enhanced nanogold reaction, which allows a more conﬁned locali-
zation of the complex. In themolecular layer, the electron opaque perox-
idase end product was observed in Purkinje cell dendrites and dendritic
spines in apparent association with cisternal organelles and membranes
of the smooth endoplasmic reticulum (Fig. 6A–B). On the other hand,
other organelles such as mitochondria, lysosomes and multivesicular
bodies, as well as the plasma membrane were unlabeled (Fig. 6A–B).
Likewise, in parallel ﬁber axons and boutons, in axon terminals forming
symmetric synapses and in glial processes we could not detect anyRTN1A-IR. The silver-enhanced immunogold reaction conﬁrmed that in
the somatodendritic domain of Purkinje cells RTN1A-IR was exclusively
intracellular. Immunometal particles decorated cisterns and vesicles of
the smooth ER in Purkinje cell dendrites (Fig. 6C) and spines (Fig. 6D).3.7. GST-RTN1523 causes a decrease in [
3H]ryanodine-binding
To assess the functional impact of RTN1A interaction on the RyR2
Ca2+-release channel, we performed equilibrium [3H]ryanodine-binding
assays on rat brain synaptosomes. Because ryanodine binds only to the
open conformation of RyR this assay is considered a reliable measure of
the open/closed state of RyR channels [42]. We determined the calcium
dependence of [3H]ryanodine binding to the population of RyR channels
present in synaptosomes from rat brain in the presence or absence of
RTN1A (puriﬁed GST-RTN1523 at 0.1 μM). In line with previous studies
for brain RyRs [43–48] our determinations showed that [3H]ryanodine
binding was similar to background levels in the virtual absence of
[Ca2+], reﬂecting the closed state of RyR channels, but was increased at
higher [Ca2+], with a characteristic “bell-shaped” [Ca2+] dependence
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Fig. 3. Immunocytochemical distribution of mCherry-RTN1523 and RyRs in HEK293 cells. (A) HEK293 cells were transiently transfected with mCherry-RTN1523 in the absence (a) or
presence of untagged RyR2 (d–f) or RyR1 (g–i). Single-transfections of untagged RyR2 (b) and RyR1 (c) were carried out as a comparison. Cells were immunostained with anti-RyR2
(b,d–f) or anti-RyR1 (c,g-i) antibodies and visualized by confocal microscopy. Note that single-transfected mCherry-RTN1523 is uniformly distributed in the cytosol (a), but altered
to a more reticular staining pattern when co-expressed with RyR2 (d–f). mCherry-RTN1523 remained uniformly distributed in cells cotransfected with RyR1 (g–i). Cells shown rep-
resent at least 20 representative cells per condition. (B) Immunoﬂuorescence confocal microscopy analysis of RyR ER localization in HEK293 cells. HEK293 cells were
single-transfected with untagged RyR1 cDNA or RyR2 cDNA, immunostained with the indicated antibodies and imaged using immunoﬂuorescence microscopy to demonstrate
RyR and calreticulin (ER-speciﬁc marker) colocalization. Cells were immunostained for RyR isoforms (green) and Calreticulin (red), respectively. Space bar: 10 μm. (C) Extent of
colocalization between mCherry-RTN1523 and RyR isoforms was quantiﬁed using Pearson correlation coefﬁcient and determined through correlation analysis with Leica SP5 soft-
ware from 10 different cells per group. (***p = 0.003 by Student's t-test).
1427L. Kaya et al. / Biochimica et Biophysica Acta 1833 (2013) 1421–1433(Fig. 7A).Maximal activation of [3H]ryanodine binding occurred between
1 and 10 μMCa2+, which is in agreement with previous studies [42–46].
Addition of 0.1 μM recombinant GST-RTN1523 speciﬁcally reduced [3H]
ryanodine binding to synaptosomes at all calcium concentrations
(Fig. 7A) without a major change in the proﬁle of Ca2+ dependence.
The presence of GST-RTN1523 did not change the minimal [Ca2+] forRyR activation (>10 nM Ca2+), and maximal activity of RyRs was
reached at the same [Ca2+] as in the absence of GST-RTN523. To com-
pare the results obtained with different vesicle preparations, binding
was normalized against the value determined in the absence of recom-
binant proteins. As shown in Fig. 7B, at 0.3 μM [Ca2+], GST-RTN1523
speciﬁcally inhibited [3H]ryanodine binding to synaptosomes by
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1428 L. Kaya et al. / Biochimica et Biophysica Acta 1833 (2013) 1421–143331.5 ± 4.3% compared to control conditions (n = 3; p = 0.011). This
effect is entirely attributable to recombinant GST-RTN1523 since
0.1 μM GST had no signiﬁcant effect (1.4 ± 5.3%) in three parallel ex-
periments. This downward shift in the [3H]-ryanodine binding pro-
duced by RTN1523, indicated a decreased Ca2+-induced activation of
RyR compared with control and is indicative of a decrease in RyR chan-
nel activity, since ryanodine binding increases as RyR activity increases.
3.8. RTN1A reduces RyR2-mediated Ca2+ oscillations
Ca2+ oscillations mediated by RyR2-expressing HEK293 cells at
increased extracellular calcium concentrations were taken as a sensi-
tive measure to detect an effect of RTN1A on RyR2 activity. As shown
in Fig. 7C, Ca2+ transients were monitored in individual HEK293 cells
expressing RyR2 in the absence or presence of RTN1A. To elicit maximal
amount of RyR2-mediated Ca2+ oscillations, cells were perfused with
1 mM [Ca2+]. By a quantitative analysis based on the overall areaunder the oscillations peaks during 450 s, the amount of Ca2+-released
via RyR2 was signiﬁcantly reduced when mcherry-RTN1A was co-
expressed in comparison to control with mcherry (Fig. 7C, left and
right upper panel, right lower panel). Furthermore, the number of
Ca2+ oscillating HEK293 cells (87.1%) was clearly reduced in the pres-
ence of RTN1A (51.9%) (Fig. 7C; right lower panel). In order to evaluate
non RTNA1-speciﬁc ER-mediated effects on RyR2, we utilized RTN4A as
an ER-resident control protein that did not interact with RyR2 based on
our co-immunoprecipitation studies. Although co-expression of RTN4A
with RyR2 slightly decreased the amount of Ca2+ released viaRyR2, this
effect was not signiﬁcant (Fig. 7C; left lower panel). Additionally, the
percent of HEK293 cells that developed RyR2-mediated Ca2+ oscilla-
tions (74.6%) was clearly above those with RTN1A co-expressed. The
magnitude of Ca2+ released during 10 mM caffeine exposure was not
substantially altered when RyR2 was co-expressed with either RTN1A
or RTN4A (Fig. 7C; right lower panel). Together, these results suggest
that a functional role for the association of RTN1Awith RyR2 in neurons
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Fig. 5. Immunohistochemical distribution pattern of RTN1A and RyR2 in rat hippocampus and cerebellum. Representative staining patterns for RTN1A (A,C,D) and RyR2 (B,E) on
sections of rat hippocampus (A,B) and cerebellar cortex (C,D,E). In the hippocampus, immunoreactivity for both proteins is found in granule cells (G), mossy ﬁber axons, and in
stratum lucidum (SL). In the cerebellum, RTN1A-immunoreactivity was conﬁned to Purkinje cell bodies (P), their dendrites in ML (C; arrow) and axons (D; arrowheads). (E) Con-
focal immunoﬂuorescent image showing RyR2 staining in Purkinje cells. Unlike RTN1A, RyR2 was also found in granule cell layer (Gl). Scale bars: A and B, 500 μm; H, hilus; G,
Granule cell layer; So, stratum oriens; Sr, stratum radiatum; Slm, stratum lacunosum molecular; Iml, inner molecular layer; M + Oml, Middle & outer molecular layer; CA1-3,
Cornu ammonis; SL, stratum lucidum; S, Subiculum; Pr, Presubiculum; Pa, Parasubiculum.
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synaptic calcium stores.
4. Discussion
Despite the abundant expression of RTN1A in the adult brain, our
understanding of its functional role still remains elusive. In this study,
using a combination of co-immunoprecipitation, colocalization, GST
pull-down assays and MS analysis we identify the intracellular calcium
release channel RyR2 as a RTN1A binding partner in neurons.Moreover,
we show that soluble RTN1523 reduces Ca2+-induced activation of RyR
on brain synaptosomes and that RTN1A markedly decreases the occur-
rence of RyR2-mediated Ca2+ oscillations at elevated extracellular
Ca2+ concentrations.
4.1. Interaction of RTN1A and RyR2
In our study we provide evidence for a direct interaction of RTN1A
and RyR2. Several approaches were used to conﬁrm this ﬁnding. First,
different RTN1A antibodies immunoprecipitated RyR2 after heterolo-
gous expression in HEK293 cells and from detergent-solubilized brain
extract. This interaction was not seen with precipitating RTN4A/NogoA
antibodies. Second, cytosolic mCherry-RTN1523 relocalized when co-
expressed with RyR2 but not with RyR1 in HEK293 cells. Third, GST-
RTN1523 afﬁnity beads were shown to pull-down RyR2 but not RyR1
from detergent-solubilized brain extract. Thus, it seems that both
proteins form a functional complex in neurons, although we cannot
completely exclude the possibility that the two proteins may indirectly
interact by virtue of each binding to an intermediary protein.
Previous studies in non-neuronal cells have suggested that all reti-
culons including RTN1A partition into the outer leaﬂet of the ER mem-
brane bilayer via their RHD, placing the N-terminal and C-terminaldomains in the cytoplasm [37,38,49,50]. Since we used the N-terminal
domain of RTN1A (aa 1–523) for interaction analysis we propose that
in intact cells RTN1A–RyR2 interaction occurs from the cytosolic surface
from the ERmembrane via cytosolic domains. More speciﬁcally, the prin-
cipal region of RTN1A responsible for binding RyR2wasmapped to HHD,
the portion of the protein spanning amino acid residues 376 and 523
(Fig. 4). No binding was detected within the N-terminal half of the pro-
tein between residues 1 and 375. Strikingly, this RyR2 binding region of
RTN1A is highly conserved among all RTN1A and RTN1B isoforms that
have so far been characterized from different species including African
clawed frog (Xenopus laevis), chicken (Gallus gallus), Carolina anole
(Anolis carolinensis), gray short-tailed opossum (Monodelphis domestica),
platypus (Ornithorhynchus anatinus), house mouse (Mus musculus),
Norwegian rat, (Rattus norvegicus), Cattle (Bos taurus), and man (Homo
sapiens), suggesting a central role for the HHD region in the function of
these two proteins. An unexpected ﬁnding from this study is the prefer-
ential interaction of RTN1A to RyR2 relative to RyR1. The similarities in
protein structure and subcellular localization between both RyRs led us
to investigate whether RyR1, like RyR2, is capable of binding to RTN1A.
Although our present biochemical analysis did not detect a RyR1 as-
sociation with RTN1A (Figs. 2D and 3), we cannot exclude that both
proteins may associate weakly/transiently, or alternatively, that
only minor amounts of these proteins interact in speciﬁc neurons.
Nevertheless, this selectivity could reﬂect preferential binding of
RTN1A to RyR2 in the absence of RyR1 such as in hippocampal
mossy ﬁbers (see below). Interestingly, in muscle cells, the two
FK506-binding proteins (FKBPs), FKBP12 and FKBP12.6, also known as
immunophilins, also exhibit selectivity binding to certain RyR subtypes.
While FKBP12 can potentially regulate all three RyR subtypes, with a
selectivity of RyR1 > RyR3 > RyR2 [51,52], FKBP12.6 associates prefer-
entially with RyR2 [53] and regulates RyR2 mediated Ca2+ release by
stabilizing the channel in its closed state [54]. Future studies will need
Fig. 6. Subcellular distribution of RTN1A in Purkinje cells. (A) Electron micrograph of a Purkinje cell dendrite immunolabeled for RTN1A (MON162 antibody) using the HRP-DAB
technique. (B) Higher magniﬁcation of the area boxed in A. The electron opaque peroxidase end product can be seen around cisternal organelles and vesicles of the smooth endo-
plasmic reticulum (indicated by ﬁlled arrows), but not the plasma membrane of the Purkinje cell. Empty arrows indicate unlabeled organelles. (C) Electron micrograph of a Purkinje
cell dendrite immunolabeled for RTN1A (MON162 antibody) using the silver-enhanced nanogold technique. Immunometal particles can be seen decorating the membrane of
cisternal organelles and vesicles of the smooth endoplasmic reticulum but not the mitochondria (m). (D) Immunometal particles for RTN1A can be observed associated with the
smooth endoplasmic reticulum within Purkinje cell spines (sp). Scale bars: A, 2 μm; B, 1 μm; C–D, 500 nm.
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RTN isoforms.
4.2. Expression and subcellular localization of RTN1A in neurons
Thus far, little information is available for detailed subcellular localiza-
tion of different RTN isoforms. Here, we explored the cellular and subcel-
lular distribution of RTN1A in detail. Immunohistochemical studies
revealed an intense labeling of RTN1A inmossyﬁbers of the hippocampus
as well as in axons, dendrites and spines of Purkinje cells. Immuno-
electron microscopy clearly showed that RTN1A was highly enriched in
dendrites and spines, and mostly distributed around the smooth ER. Al-
though RTNs are generally thought to be predominantly located in the
endomembrane system, RTN4A, -B, -C andRTN2Bwere reported to reside
also on the cell surface of neurons and non-neuronal cells [55,56,36,4]. In
contrast, in our immunoelectron microscopy study we did not observe
plasma membrane associated RTN1A-IR in Purkinje cells (Fig. 6). This
ﬁnding is in perfect agreementwith previous cell surface biotinylation as-
says on cultured neurons, which failed to detect cell surface-exposed
RTN1A [4].Moreover, in contrast to the RHDof RTN2, - 3 and−4proteins,
RHD of RTN1 lacks binding to the axonal Nogo-66 receptor, NgR1 [57]
thought to be responsible for axonal growth inhibition. Hence, it seems
likely that RTN1A exerts primarily an intracellular function related to its
localization within the ER of pre- and postsynaptic sites. Although
RTN1A shows a similar distribution in the brain as the RyR2 channel, it
also exhibits a distinct expression pattern compared to RyR2when exam-
ined in detail locally. For example, both proteins are highly expressed in
cerebellum; however, RTN1A is more abundant in Purkinje cells whereas
RyR2-IR is strong in granule cells, which are clearly devoid of RTN1A-IR,
implying that RTN1A/RyR2 association may play distinct roles in subre-
gions of the cerebellum.4.3. Physiological function of RTN1A–RyR2 association
At present, the physiological signiﬁcance of the RTN1A–RyR2 asso-
ciation remains to be deﬁned. However, it is tempting to speculate
that RTN1A might exert a regulatory effect on RyR2 channel function.
Initial evidence for a modulatory role of RTN1A is provided by our
ryanodine binding assays, showing that soluble RTN1523 inhibits the
calcium-dependent activation of [3H]ryanodine binding in forebrain
synaptosomes by 32% (Fig. 7A,B). Because RyR2 was shown to be the
most abundant isoform of total RyR content in mammalian brain cortex
[58,41],we assume that this decrease in [3H]ryanodine binding is largely
attributable to RTN1523 association to RyR2. Consistent with this view,
we have shown that RTN1A reduces the frequency of RyR2-mediated
Ca2+ oscillations in HEK293 cells expressing RyR2. Although this effect
appeared to be speciﬁc for RTN1A, we cannot fully exclude that over-
expression of RTN1A in the ER additionally contributed to its speciﬁc in-
hibitory action on RyR2 function. Hence, the apparent close physical
proximity of the RyR2 and RTN1A in Purkinje cells or in mossy ﬁbers
in the hippocampus (Fig. 5) may enable RTN1A to bind to the RyR2
channel with high avidity even when cytoplasmic Ca2+ concentration
is low under resting conditions. Accordingly, RyR2 channels that are
bound to RTN1A may have a lower open probability, resulting in a de-
creased sensitivity to RyR2-mediated CICR. Emerging evidence indicates
that CICR appears to play a vital role in neuronal functions including
those that regulate synaptic efﬁcacy, aging and memory. CICR has been
demonstrated in neurons where intracellular Ca2+ release from RyRs
is found to be linked to Ca2+ inﬂux through voltage-dependent chan-
nels [59]. In cerebellar Purkinje cells, for example, Ca2+ inﬂux via activa-
tion of both ionotropic and metabotropic glutamate receptors is shown
to be essential for subsequent RyR-mediated Ca2+ release [60]. In addi-
tion, RyR mediated Ca2+ release from intracellular stores is reported to
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Fig. 7. GST-RTN1523 inhibits speciﬁc [3H]ryanodine binding to rat brain synaptosomes. (A) Equilibrium [3H]ryanodine binding to rat forebrain synaptosomalmembrane preparationswas
carried out in binding buffer containing 10 nM [3H]ryanodine at the indicated free calcium concentrations in control conditions (closed circles) and in the presence of 0.1 μMGST (closed
triangles) or 0.1 μMGST-RTN1523 (open squares). [Ca2+] was maintained, in the range 0.01 μM–1 mM, by a combination of EGTA and CaCl2. Free Ca2+ concentrations were calculated as
described in material and methods. Data points shown are the mean ± S.E.M., from three separate experiments performed in triplicates. (B) [3H]ryanodine binding in the presence of
0.1 μM GST or GST-RTN1523 is presented as percent of control. No speciﬁc [3H]ryanodine binding was observed at 0.01 μM Ca2+ in the presence of GST or GST-RTN1523. Difference in
[3H]ryanodine binding was plotted as percent decrease in speciﬁc binding. Data points shown are the mean ± S.E.M., from three separate experiments (*p = 0.011 by Student's
t-test). (C) RyR2 evoked Ca2+ oscillations in HEK293. Upper and lower left panels represent Fura-2 ratio time-courses of single cells expressing RyR2 together with mcherry,
mcherry-RTN1A or EGFP-RTN4A. Cells were continuously perfused with buffer containing 0 mM Ca2+ (nominal free), 1 mM Ca2+ and 0 mM Ca2+ + 10 mM caffeine as indicated by
the bars at the top. Lower right panel shows a quantitative analysis performed by integration of the respective single peak areas referred to area under curve for estimation of the total
amount of the cytosolic [Ca2+] arising through RyR2 dependent Ca2+ oscillations. The fraction of cells that showed both oscillations as well as a clear caffeine peak in comparison to
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[61,62] and long-term depression in both the hippocampus and cerebel-
lum [63–66]. Notably, in the hippocampus, activity dependent presynap-
tic CICR at the mossy ﬁber synapse is mediated by RyR2 [40], thereby
facilitating robust presynaptic forms of plasticity at the mossy ﬁber-CA3
synapse. Hippocampal expression of RyR2 increases after spatial memory
learning [63] and is involved in BDNF-induced hippocampal synaptic
plasticity and spatial memory formation [67].
The RTN1A and RyR2 associationmight not only be involved in neuro-
transmitter release but also in aging-related Ca2+ dysregulation. Similar
as in the muscle (see above), neuronal FKBP12.6 inhibits cytosolic Ca2+
rises by inhibiting directly L-VGCCs and RyR2. Interestingly, experimental
silencing or downregulation of FKBP12.6, led to hippocampal Ca2+dysregulation resulting in dampened neuronal excitability and function,
typical signs of aging or pathological neurons [68]. Thus, in analogy, it is
possible to envision that, in neurons, RTN1A may function together
with RyR2 and FKBPmolecules in amultimeric Ca2+ regulating complex,
inwhich RTN1A and FKBP12.6 tonically inhibit RyR2 bydirect interaction.
In conclusion, we identiﬁed RyR2 as a novel binding partner of
RTN1A and show that RTN1A exerts a regulatory, inhibitory effect on
the RyR2 activity. These results suggest that a functional coupling of
RTN1A and RyR2may play a vital role in controlling regulation of neuro-
transmitter release and long-term potentiation induction bymodulation
of intracellular Ca2+ release.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2013.02.012.
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